OMCL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Omnicell Inc (OMCL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance shows declining profitability, insiders are selling heavily, and there is no strong AI Stock Picker signal. While the SwingMax signal indicates a potential swing trade opportunity, this is not aligned with a long-term investment strategy. Analysts are optimistic about the Titan XT launch, but the muted guidance and lack of immediate catalysts make this a hold for now.
The MACD is positive and expanding, suggesting bullish momentum. RSI is neutral at 66.443, and moving averages are converging, indicating no strong trend. The stock is trading near its R1 resistance level of 41.743, with support at 36.655.
The company is positioned for a potential 'super-cycle' driven by competitive wins and replacement cycles.
Insiders are selling heavily, with a 151.38% increase in selling over the last month. Financial performance is weak, with a YoY net income drop of -112.79% and gross margin decline of -10.87%. The pre-market price is down -1.24%, and there is no recent news to drive positive sentiment.
In Q4 2025, revenue increased by 2.32% YoY to $313.98M, but net income dropped significantly to -$2.03M (-112.79% YoY). EPS fell to -$0.05 (-114.71% YoY), and gross margin declined to 41.51% (-10.87% YoY).
Analysts are generally positive, with recent upgrades and price target increases. However, Piper Sandler lowered its price target to $49 due to muted guidance, while BofA and KeyBanc have higher targets of $70 and $60, respectively, citing long-term growth potential from the Titan XT launch.
